Wntrix Inc. is a preclinical-stage biotechnology company aiming to discover and develop novel therapeutics using the antibody drug conjugate (ADC) approach for solid tumors. Wntrix was founded in 2014 at Houston, Texas.
Wntrix Inc. is a preclinical-stage biotechnology company aiming to discover and develop novel therapeutics using the antibody drug conjugate (ADC) approach for solid tumors. Wntrix was founded in 2014 at Houston, Texas.